Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
ETFYour view on NVOH
Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
ETFADR hedgedSentiment
AUM (USD)
$4.26M
Expense Ratio
0.19%
Holdings
0
Sentiment
Overview for Precidian ETFs Trust - Novo Nordisk A/S (B Shares) ADRhedged
- Fund Type
- ETF
- Fund Issuer
- ADR hedged
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- January 2, 2025
- Domicile
- DK
- Website
- precidianetfs.com/etf/nvoh
- Fund Type
- ETF
- Fund Issuer
- ADR hedged
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- January 2, 2025
- Domicile
- DK
- Website
- precidianetfs.com/etf/nvoh
- Fund Type
- ETF
- Fund Issuer
- ADR hedged
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- January 2, 2025
- Domicile
- DK
- Website
- precidianetfs.com/etf/nvoh
About this fund
The series, under normal circumstances, invests at least 95% of its net assets in American Depositary Receipts (“ADRs”) of the Novo Nordisk A/S (B Shares) (the “Company”). The series will not invest directly in the company. The fund is non-diversified.
NVOH Stock Price
Key Facts
EquityExpense Ratio
0.19%
AUM
$4.26M
Fund Details
Expense Ratio
0.19%
Assets Under Management
$4.26M
NAV
$24.36 USD
Average Volume
2.1K
Inception Date
January 2, 2025
Asset Class
Equity
Fund Issuer
ADR hedged
Domicile
DK
ISIN
US74016W8414
CUSIP
74016W841
NAV Currency
USD
Expense Ratio
0.19%
Assets Under Management
$4.26M
NAV
$24.36 USD
Average Volume
2.1K
Inception Date
January 2, 2025
Asset Class
Equity
Fund Issuer
ADR hedged
Domicile
DK
ISIN
US74016W8414
CUSIP
74016W841
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.